Tissue Engineered Skin Substitute Market
Market Insights on Tissue Engineered Skin Substitute covering sales outlook, demand forecast & up-to-date key trends
Tissue Engineered Skin Substitute Market by Product (Acellular Skin Substitutes, Biologic Skin Substitute, Cellular Skin Substitutes and Synthetic Skin Substitutes), Material (Synthetic and Natural) & Region - Forecast 2022 - 2029
Tissue Engineered Skin Substitute Market Snapshot
[248 Pages Report] The global Tissue Engineered Skin Substitute Market was valued at US$ 2.01 Bn in 2021 and is expected to reach US$ 4.13 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey.
Data Points |
Market Insights |
Market Value 2022 |
USD 2.2 Bn |
Market Value 2029 |
USD 4.1 Bn |
CAGR 2022-2029 |
9.6% |
Key Players |
The key players are Smith & Nephew plc., Acelity L.P. Inc., Mölnlycke Health Care, Integra Life Sciences, Allergan plc, Regenicin, Organogenesis Inc., MiMedx, LifeNet Health, Kerecis and Medline Industries, Inc. |
Share of Top 5 Countries |
75.9% |
Increasing demand for minimally invasive surgeries, growing geriatric population, growing incidences of diabetic foot ulcers, increasing vascular diseases & burn injuries, development in the healthcare infrastructure and growing government investment are primary factors expected to boost the tissue engineered skin substitute market growth.
In addition, the need for tissue engineered skin substitutes is growing because of the growing occurrence of chronic and acute wounds, great demand for skin grafts, technological advancements in healthcare, and increasing awareness regarding different treatment options.
Tissue Engineered Skin Substitute market holds nearly 5.2% market value share of the US$ 39 Bn Wound Care Management Market in 2021. The market is likewise gaining traction due to the increasing inclination among the population to spend more and choose for advanced and new burn care products.
Driven by this, sales of tissue engineered skin substitutes are expected to rise at a 9.6% CAGR through 2029.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
Particulars |
Details |
H1, 2021 |
9.04% |
H1, 2022 Projected |
9.56% |
H1, 2022 Outlook |
9.46% |
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
BPS Change – H1, 2022 (O) – H1, 2021 |
(+) 43 ↑ |
FMI has provided a comparative analysis of market growth rates and future opportunities in the worldwide tissue engineered skin substitute market. Regulatory approvals for biomaterials and innovation determinants, as well as the impact of macro and industry dynamics, will have an influence on the market.
Advanced wound therapies include the use of bioengineered artificial skin substitutes and topical release of mesenchymal stem cells to reduce inflammation and speed up the healing process in order to overcome graft rejection. This element accounts for one of the most significant advantages of tissue generated skin substitutes.
As per the analysis by Future Market Insights, the market is expected to increase by 43 Basis Point Share (BPS) in H1-2022 (O) as compared to H1- 2021. H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 10 BPS.
Major reasons for this rise in BPS is attributed to the property of tissue engineered skin substitutes in providing both epidermal and dermal constituents required to attain functional closure of wound, and have thus been adopted for efficient closure of full-thickness burn wounds, as well as treating burns that are larger than 50% of the total burn surface area.
In the second half of the projection period, other market categories are expected to do fairly well and have excellent growth possibilities. Reduced vascularization, poor mechanical integrity, inability to integrate, scarring, and immunological rejection have all been documented with various commercially available tissue engineered skin substitutes, all of which are deterrents to the industry's expansion.
2014-2021 Tissue Engineered Skin Substitute Market Demand Outlook Compared to 2022-2029 Forecast
Sales of tissue engineered skin substitute grew at a CAGR of 6.4% between 2014 and 2021.
Some of the major factors that are fueling the market development include growing prevalence of trauma cases, growing burn & chronic wounds, and increasing focus on technological advancements. Moreover, according to the WHO, almost 1.4 million people die from road accidents each year.
In addition, increasing prevalence of diabetes is anticipated to drive the market growth. This is owing to the increased probability of developing a diabetic foot ulcer gradually in diabetic patients. For instance, according to a report published by WHO, the occurrence of diabetes for the global population was estimated to be 9.3% in 2019 and 10.2% in 2030. Hence, as a result, the prevalence of diabetes-associated complications is anticipated to rise over the forecast years.
Moreover, growing awareness level amongst the population regarding several treatment options is a primary factor boosting the tissue engineered skin substitutes market. Existence of government organizations like non-profit organizations such as the ABA (American Burn Association) and WHO (World Health Organization) similarly add towards growing awareness levels.
Considering this, FMI expects the global tissue engineered skin substitute market to grow at a CAGR of 9.6% through 2029.
Which Factors Are Restraining Demand for Tissue Engineered Skin Substitute?
Limited awareness among rural population and inability to reproduce skin appendages are major factors hindering the growth of tissue engineered skin substitute market. Low awareness regarding the available treatment options for chronic wounds and their possible treatment modalities available in the market among healthcare professionals in the rural areas are factors expected to limit the demand for skin substitute products. Limited infrastructure and lack of sophisticated health systems results in the less awareness among the people.
The inability of producing skin appendages is one of the key factors that is anticipated to hamper the market development sooner rather than later. In addition, increased time consumption for development of skin substitute is another factors hampering the market development.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat is the Impact of the COVID-19 Crisis on the Tissue Engineered Skin Substitute Market?
COVID-19 pandemic is projected to have a major impact on the development of the studied market. The market observed a huge slowdown in its growth due to the spread of Covid-19 pandemic worldwide.
The pandemic has had a negative effect on the market. Some companies reported a drop in their sales in 2020 because of the pandemic. Similarly, the government of key nations allotted their healthcare resources in wound clinics, including nurses, beds, and necessary personnel to help COVID-19 patients.
Moreover, a number of medical administrations delivered guidelines about the handling of patients with difficult wounds. For example, the IWGDF (International Working Group on the Diabetic Foot) suggested using other options to outpatient clinics or hospitals. The organization suggested a change towards telemedicine, development of clinics in other places away from the home visits or hospital for patients experiencing from less difficult chronic wounds. This is leading to decline in the hospital visits thus hampering the market growth.
Country-wise Insights
What Makes the U.S. a Large Market for Tissue Engineered Skin Substitute?
The U.S. is estimated to account for around 97.3% of the North America tissue engineered skin substitute market in 2022.
This is mainly owing to the increasing number of burn injuries, technological advancements in the healthcare industry, and the availability of major players in the country. In addition, factors such as growing occurrence of acute and chronic wound, modifications in reimbursement policy, and support from government in the form of finance for development of innovative wound care products are offering required drive for growth of the market.
Why is Germany Considered a Lucrative Tissue Engineered Skin Substitute Market?
Germany is estimated to account for 27.1% of the Europe tissue engineered skin substitute market in 2022.
The growth drivers for the market in Germany are huge patient population, high healthcare expenditures, government support for research & development and accessibility of funds for research. In addition, increasing incidence of chronic wounds is expected to contribute to the growth in the country.
Underlying diseases, which might result in chronic wounds, such as diabetes or venous diseases, are increasing due to changing life styles and are also age-related. It has been observed that the prevalence rate is higher in the population aged over 65 for chronic ulceration. These factors are increasing the demand for wound care which in turn is leading to market development.
What are the Factors Fueling the Demand for Tissue Engineered Skin Substitute in China?
The tissue engineered skin substitute market in China is estimated to be worth US$ 82.5 Mn in 2022 in the global market.
The tissue engineered skin substitute market in China is projected to develop due to growing demand for rapid recovery of wounds and increasing occurrence of chronic wounds and a rise in the number of diabetic foot ulcers.
The pervasiveness of diabetes is found to be increasing in China, as a result, there is rising demand for skin care, so as to decrease the risk of wounds such as diabetic foot ulcers. The occurrence of chronic wounds particularly foot ulcers surges among the diabetic population. Due to this there is increasing need for skin substitution such as skin grafting, which is increasing the demand for the overall market.
How will the Tissue Engineered Skin Substitute Market Expand across India?
Demand for tissue engineered skin substitute in India is expected to rise at around 10.2% CAGR over the forecast period.
India is one of the fastest growing market in Asia owing to growing number of road accidents and subsequent presence of favorable reimbursement policies like National Health Insurance.
India is one of the countries with high number of road accident cases due to over population and lack of traffic security. According to the ministry of road transport and highways, around 4.5 lakh road accidents occur per year in India, out of which 1.5 lakh people die. In addition, burns and traumatic injuries are some of the major factors of acute wounds, which require advanced therapies.

A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-wise Insights
Demand for Biologic Skin Substitute to continue gaining Traction
By product, biologic skin substitute is anticipated to hold the maximum share of 48.7% in 2022, expanding at rate of nearly 10.1% during the forecast period.
The biological skin substitutes segment capture the largest market share due to the growing pervasiveness of acute wounds around the globe. The main advantage of biological skin substitutes is that skin is easily accessible from the patient itself. Biological skin substitutes have additional extracellular matrix that aids in exceptional re-epithelialization and rapid healing of the wound. Such advantages of biological skin substitutes over other substitutes is increasing the demand for the segment.
Why Natural material will hold the most of the market share?
By material, Natural segment will lead the market and is projected to account for 82.9% of the global market revenue share in 2022.
The advantages provided by natural skin substitutes over other materials is increasing the demand for natural material in skin substitutes. Natural material can be utilized in situations where sufficient skin grafts are not obtainable, for instance, in extensive burns. Also this material avoids the formation of additional wounds and also offers temporary barrier to the wounds until the grafting is completed.
Which application is most sought-after over the forecast period?
By application, chronic wounds will be the most sought-after application and is projected to account for 70.4% of the total market revenue share in 2022.
Expanding penetration of skin substitutes in wound care and treatment of diabetic foot ulcers, and pressure ulcers leads to high market share of chronic wounds. In addition, growing demand for breast reconstruction is expected to further strengthen growth of the market. Also, increasing geriatric population suffering from diabetes is surging the demand for the tissue engineered skin substitute market.
Why Hospitals projected maximum growth in the Tissue Engineered Skin Substitute Market?
By end user, the hospitals segment is anticipated to hold the maximum share of 54.1% in 2022, expanding at rapid rate of 10.0% CAGR during the forecast period.
Hospitals lead among all end users in the market due to the increasing number of surgeries globally. The growing cases of venous leg ulcers and diabetic foot ulcers are the other key factors boosting the segment growth. Moreover, rising number of surgical wound cases owing to growing number of surgical procedures is adding to the segment growth. Also, presence of well-developed infrastructure and availability of advanced equipment supports the development of the segment.
Competitive Landscape
Companies operating in the tissue engineered skin substitute market are fairly competitive by nature, with a presence of few players. These players are involved in a number of strategic alliances. The product launch and acquisition accelerates the manufacturer’s strategy to capitalize on the market share and capture the significant share of market. Some of the recent instances include:
- In September 2020, MiMedx Group, Inc. announced the launch of EpiCord Expandable, the latest advancement in its portfolio of products. At the core of this technology is EpiCord, which has demonstrated clinical efficacy in the treatment of diabetic foot ulcers.
Scope of the Report
Attribute |
Details |
Forecast Period |
2014-2021 |
Historical Data Available for |
2022-2029 |
Market Analysis |
USD Million for Value |
Key Countries Covered |
US, Canada, Brazil, Mexico, Argentina, Germany, U.K., France, Italy, Spain, BENELUX, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, South Africa |
Key Segments Covered |
Product, Material, Application, End User and Region |
Key Companies Profiled |
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Customization & Pricing |
Available upon Request |
Tissue Engineered Skin Substitute Market by Category
By Product:
- Acellular Skin Substitutes
- Acellular skin substitutes based on Amniotic Membrane
- Other Acellular skin substitutes
- Biologic Skin Substitute
- Allograft
- Xenograft
- Cellular Skin Substitutes
- Cellular skin substitute based on amniotic membrane
- Other cellular skin substitutes
- Synthetic Skin Substitutes
By Material:
- Synthetic
- Natural
By Application:
- Chronic Wounds
- Venous leg Ulcers
- Diabetic Foot Ulcer
- Pressure Ulcers
- Acute Wounds
- Traumatic Wounds
- Burn Cases
- Other Applications
By End User:
- Hospital
- Specialty Clinics
- Ambulatory Surgical Centers
- Research Laboratory
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
The global tissue engineered skin substitute market is worth US$ 2.01 Bn in 2021 and is set to expand 1.9X over the forecasted years owing to the rising diabetic foot ulcers and growing demand for wound care.
The sales of tissue engineered skin substitute in the market have grown at a CAGR of nearly 6.4% between 2014 and 2021. The need for tissue engineered skin substitutes is growing because of the growing occurrence of chronic and acute wounds, great demand for skin grafts, technological advancements in healthcare, and increasing awareness regarding different treatment options.
The tissue engineered skin substitute market is expected to reach US$ 4.13 Bn by the end of 2029 with sales revenue expected to register CAGR of 9.6% over the forecast period.
North America currently holds the largest market revenue share in the global tissue engineered skin substitute market with 60.9% in 2021. U.S. is the leading contributor with a market value over US$ 1.19 Bn in 2022.
Demand of tissue engineered skin substitute market is expected to register growth in Europe at rate of 6.7% CAGR during the forecast period.
The tissue engineered skin substitute market in China is likely to observe growth with an impressive CAGR of 8.4% during the forecast period. The key factors responsible for the growth of the market in China include need for rapid recovery of wounds and increasing occurrence of chronic wounds and a rise in the number of diabetic foot ulcers.
Introduction of novel designs of skin substitutes, increasing research funding for development of tissue engineered skin and increasing number of mergers and acquisitions are key trends driving sales of tissue engineered skin substitute market across the globe.
Japan’s tissue engineered skin substitute market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 7.7% CAGR during the forecast period. South Korea market is expected to exhibit healthy growth of 6.8% CAGR during the forecast period.
U.S., Germany, China, UK and France are the top 5 countries that are driving the demand for tissue engineered skin substitute market.
Leading companies of tissue engineered skin substitute are Smith & Nephew plc, Acelity L.P. Inc., Mölnlycke Health Care, Integra Life Sciences, Allergan plc, Regenicin, Organogenesis Inc., MiMedx, LifeNet Health, Kerecis and Medline Industries, Inc.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Technological Developments
4. Key Success Factors
4.1. Reimbursement Scenario
4.2. Regulatory Scenario
4.3. Pipelined Products
4.4. Disease Epidemiology
4.5. Product Characterization
5. Global Market - Pricing Analysis
5.1. Regional Pricing Analysis By Product Type
5.2. Global Average Pricing Analysis Benchmark
6. Global Market Analysis 2014-2021 and Forecast, 2022-2029
6.1. Historical Market Value (US$ Mn) Analysis, 2014-2021
6.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Market Background
7.1. Macro-Economic Factors
7.1.1. Global GDP Growth Outlook
7.1.2. Global Healthcare Expenditure Outlook
7.1.3. High Disposable Income
7.1.4. Reference Pricing
7.1.5. Healthy Economic Growth In Emerging Countries
7.2. Forecast Factors - Relevance & Impact
7.2.1. Increasing Prevalence of Chronic Wound
7.2.2. Rise in Burn Cases
7.2.3. Product Approval
7.2.1. Extensive Network of End Users
7.2.2. Distribution Channel
7.3. Market Dynamics
7.3.1. Drivers
7.3.2. Restraints
7.3.3. Opportunity Analysis
8. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2022-2029
8.3.1. Acellular Skin Substitutes
8.3.1.1. Acellular Skin Substitutes based on Amniotic Membrane
8.3.1.2. Other Acellular Skin Substitutes
8.3.2. Biologic Skin Substitutes
8.3.2.1. Allograft
8.3.2.2. Xenograft Acellular
8.3.3. Cellular Skin Substitutes
8.3.3.1. Cellular Skin Substitutes based on Amniotic Membrane
8.3.3.2. Other Cellular Skin Substitutes
8.3.4. Synthetic Skin Substitutes
8.4. Market Attractiveness Analysis By Product Type
9. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Material
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Material, 2014-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Material, 2022-2029
9.3.1. Natural
9.3.2. Synthetic
9.4. Market Attractiveness Analysis By Material
10. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Application, 2014-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2029
10.3.1. Chronic Wounds
10.3.1.1. Venous Leg Ulcers
10.3.1.2. Diabetic Foot Ulcers
10.3.1.3. Pressure Ulcers
10.3.2. Acute Wounds
10.3.2.1. Traumatic Wounds
10.3.2.2. Burn Cases
10.3.3. Other Applications
10.4. Market Attractiveness Analysis By Application
11. Global Market Analysis 2014-2021 and Forecast 2022-2029, by End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By End User, 2014-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2029
11.3.1. Hospital
11.3.2. Specialty Clinic
11.3.3. Ambulatory Surgical Center
11.3.4. Research Laboratory
11.4. Market Attractiveness Analysis By End User
12. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2021
12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2029
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. MEA
12.3.7. Oceania
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2014-2021 and Forecast 2022-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product Type
13.3.3. By Material
13.3.4. By Application
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.5. Drivers and Restraints - Impact Analysis
14. Latin America Market Analysis 2014-2021 and Forecast 2022-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product Type
14.3.3. By Material
14.3.4. By Application
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints - Impact Analysis
15. Europe Market Analysis 2014-2021 and Forecast 2022-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Product Type
15.3.3. By Material
15.3.4. By Application
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints - Impact Analysis
16. South Asia Hysteroscopy Systems Market Analysis 2014-2021 and Forecast 2022-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product Type
16.3.3. By Material
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints - Impact Analysis
17. East Asia Hysteroscopy Systems Market Analysis 2014-2021 and Forecast 2022-2029
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product Type
17.3.3. By Material
17.3.4. By Application
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.5. Drivers and Restraints - Impact Analysis
18. Oceania Market Analysis 2014-2021 and Forecast 2022-2029
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product Type
18.3.3. By Material
18.3.4. By Application
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.5. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Market Analysis 2014-2021 and Forecast 2022-2029
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. South Africa
19.3.1.3. Rest of Middle East and Africa
19.3.2. By Product Type
19.3.3. By Material
19.3.4. By Application
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.5. Drivers and Restraints - Impact Analysis
20. Emerging Countries Market Analysis 2014-2021 and Forecast 2022-2029
20.1. Introduction
20.1.1. Market Value Proportion Analysis, By Key Countries
20.1.2. Global Vs. Country Growth Comparison
20.2. India Market Analysis
20.2.1. Introduction
20.2.2. Market Value Proportion Analysis by Market Taxonomy
20.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.2.3.1. By Product Type
20.2.3.2. By Material
20.2.3.3. By Application
20.2.3.4. By End User
20.2.4. Market Attractiveness Analysis
20.3. China Market Analysis
20.3.1. Introduction
20.3.2. Market Value Proportion Analysis by Market Taxonomy
20.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.3.3.1. By Product Type
20.3.3.2. By Material
20.3.3.3. By Application
20.3.3.4. By End User
20.3.4. Market Attractiveness Analysis
20.4. Brazil Market Analysis
20.4.1. Introduction
20.4.2. Market Value Proportion Analysis by Market Taxonomy
20.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.4.3.1. By Product Type
20.4.3.2. By Material
20.4.3.3. By Application
20.4.3.4. By End User
20.4.4. Market Attractiveness Analysis
21. Market Structure Analysis
21.1. Market Share Analysis
21.2. Market Concentration
21.3. Competition Mapping
22. Competition Analysis
22.1. Company Dashboard
22.2. Company Profile
22.2.1. Smith & Nephew plc.
22.2.1.1. Overview
22.2.1.2. Service Portfolio
22.2.1.3. Analyst Commentary
22.2.2. Acelity L.P. Inc.
22.2.2.1. Overview
22.2.2.2. Service Portfolio
22.2.2.3. Analyst Commentary
22.2.3. Mölnlycke Health Care
22.2.3.1. Overview
22.2.3.2. Service Portfolio
22.2.3.3. Analyst Commentary
22.2.4. Integra Life Sciences
22.2.4.1. Overview
22.2.4.2. Service Portfolio
22.2.4.3. Analyst Commentary
22.2.5. Allergan plc
22.2.5.1. Overview
22.2.5.2. Service Portfolio
22.2.5.3. Analyst Commentary
22.2.6. Regenicin
22.2.6.1. Overview
22.2.6.2. Service Portfolio
22.2.6.3. Analyst Commentary
22.2.7. Organogenesis Inc.
22.2.7.1. Overview
22.2.7.2. Service Portfolio
22.2.7.3. Analyst Commentary
22.2.8. MiMedx
22.2.8.1. Overview
22.2.8.2. Service Portfolio
22.2.8.3. Analyst Commentary
22.2.9. LifeNet Health
22.2.9.1. Overview
22.2.9.2. Service Portfolio
22.2.9.3. Analyst Commentary
22.2.10. Kerecis
22.2.10.1. Overview
22.2.10.2. Service Portfolio
22.2.10.3. Analyst Commentary
22.2.11. Medline Industries, Inc.
22.2.11.1. Overview
22.2.11.2. Service Portfolio
22.2.11.3. Analyst Commentary
23. Assumptions and Acronyms Used
24. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 02: Global Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Material Type
Table 03: Global Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application
Table 04: Global Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 05: Global Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Region
Table 06: North America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 07: North America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 08: North America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Material
Table 09: North America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application
Table 10: North America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 11: Latin America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 12: Latin America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 13: Latin America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Material
Table 14: Latin America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application
Table 15: Latin America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 16: Europe Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 17: Europe Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 18: Europe Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Material
Table 19: Europe Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application
Table 20: Europe Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 21: South Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 22: South Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 23: South Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Material
Table 24: South Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application
Table 25: South Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 26: East Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 27: East Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 28: East Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Material
Table 29: East Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application
Table 30: East Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 31: Oceania Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 32: Oceania Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 33: Oceania Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Material
Table 34: Oceania Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application
Table 35: Oceania Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 36: MEA Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 37: MEA Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 38: MEA Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Material
Table 39: MEA Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application
Table 40: MEA Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 41: India Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 42: India Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, by Material
Table 43: India Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application
Table 44: India Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 45: China Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 46: China Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, by Material
Table 47: China Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application
Table 48: China Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 49: Brazil Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type
Table 50: Brazil Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, by Material
Table 51: Brazil Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Application
Table 52: Brazil Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Cellular Skin Substitutes Based on Amniotic Membrane, Price Difference (US$ Mn) By Region, 2022
Figure 02: Global Other Cellular Skin Substitutes (US$ Mn) By Region, 2022
Figure 03: Global Acellular Skin Substitutes Based on Amniotic Membrane, Price Difference (US$ Mn) By Region, 2022
Figure 04: Global Other Acellular Skin Substitutes (US$ Mn) By Region, 2022
Figure 05: Global Biological Skin Substitute (Allograft), Price Difference (US$ Mn) By Region, 2022
Figure 06: Global Biological Skin Substitute (Xenograft) (US$ Mn) By Region, 2022
Figure 07: Global Synthetic Skin Substitute, Price Difference (US$ Mn) By Region, 2022
Figure 08: Global Market Value Analysis (US$ Mn), 2014-2021
Figure 09: Global Market Value Forecast (US$ Mn), 2022-2029
Figure 10: Global Devices Market Absolute $ Opportunity, 2022-2029
Figure 11: Global Market Share Analysis (%) By Product Type, 2022 & 2029
Figure 12: Global Market Y-o-Y Growth (%) By Product Type, 2022-2029
Figure 13: Global Market Attractiveness Analysis, By Product Type
Figure 14: Global Market Share Analysis (%) By Material Type, 2022 & 2029
Figure 15: Global Market Y-o-Y Growth (%) By Material Type, 2022-2029
Figure 16: Global Market Attractiveness Analysis, By Material Type
Figure 17: Global Market Share Analysis (%) By Application, 2022 & 2029
Figure 18: Global Market Y-o-Y Growth (%) By Application, 2022-2029
Figure 19: Global Market Attractiveness Analysis, By Application
Figure 20: Global Market Share Analysis (%) By End User, 2022 & 2029
Figure 21: Global Market Y-o-Y Growth (%) By End User, 2022-2029
Figure 22: Global Market Attractiveness Analysis, By End User
Figure 23: Global Market Share Analysis (%) By Region, 2022 & 2029
Figure 24: Global Market Y-o-Y Growth (%) By Region, 2022-2029
Figure 25: Global Market Attractiveness Analysis, By Region
Figure 26: North America Market Value Share, by Country (2022)
Figure 27: North America Market Value Share, by Product (2022)
Figure 28: North America Market Value Share, by Material (2022)
Figure 29: North America Market Value Share, by Application (2022)
Figure 30: North America Market Value Share, by End User (2022)
Figure 31: North America Market Attractiveness Analysis, By Country
Figure 32: North America Market Attractiveness Analysis, By Product Type
Figure 33: North America Market Attractiveness Analysis, By Material
Figure 34: North America Market Attractiveness Analysis, Application
Figure 35: North America Market Attractiveness Analysis, By End User
Figure 36: Latin America Market Value Share, by Country (2022)
Figure 37: Latin America Market Value Share, by Product (2022)
Figure 38: Latin America Market Value Share, by Material (2022)
Figure 39: Latin America Market Value Share, by Application (2022)
Figure 40: Latin America Market Value Share, by End User (2022)
Figure 41: Latin America Market Attractiveness Analysis, By Country
Figure 42: Latin America Market Attractiveness Analysis, By Product Type
Figure 43: Latin America Market Attractiveness Analysis, By Material
Figure 44: Latin America Market Attractiveness Analysis, Application
Figure 45: Latin America Market Attractiveness Analysis, By End User
Figure 46: Europe Market Value Share, by Country (2022)
Figure 47: Europe Market Value Share, by Product (2022)
Figure 48: Europe Market Value Share, by Material (2022)
Figure 49: Europe Market Value Share, by Application (2022)
Figure 50: Europe Market Value Share, by End User (2022)
Figure 51: Europe Market Attractiveness Analysis, By Country
Figure 52: Europe Market Attractiveness Analysis, By Product Type
Figure 53: Europe Market Attractiveness Analysis, By Material
Figure 54: Europe Market Attractiveness Analysis, Application
Figure 55: Europe Market Attractiveness Analysis, By End User
Figure 56: South Asia Market Value Share, by Country (2022)
Figure 57: South Asia Market Value Share, by Product (2022)
Figure 58: South Asia Market Value Share, by Material (2022)
Figure 59: South Asia Market Value Share, by Application (2022)
Figure 60: South Asia Market Value Share, by End User (2022)
Figure 61: South Asia Market Attractiveness Analysis, By Country
Figure 62: South Asia Market Attractiveness Analysis, By Product Type
Figure 63: South Asia Market Attractiveness Analysis, By Material
Figure 64: South Asia Market Attractiveness Analysis, Application
Figure 65: South Asia Market Attractiveness Analysis, By End User
Figure 66: East Asia Market Value Share, by Country (2022)
Figure 67: East Asia Market Value Share, by Product (2022)
Figure 68: East Asia Market Value Share, by Material (2022)
Figure 69: East Asia Market Value Share, by Application (2022)
Figure 70: East Asia Market Value Share, by End User (2022)
Figure 71: East Asia Market Attractiveness Analysis, By Country
Figure 72: East Asia Market Attractiveness Analysis, By Product Type
Figure 73: East Asia Market Attractiveness Analysis, By Material
Figure 74: East Asia Market Attractiveness Analysis, Application
Figure 75: East Asia Market Attractiveness Analysis, By End User
Figure 76: Oceania Market Value Share, by Country (2022)
Figure 77: Oceania Market Value Share, by Product (2022)
Figure 78: Oceania Market Value Share, by Material (2022)
Figure 79: Oceania Market Value Share, by Application (2022)
Figure 80: Oceania Market Value Share, by End User (2022)
Figure 81: Oceania Market Attractiveness Analysis, By Country
Figure 82: Oceania Market Attractiveness Analysis, By Product Type
Figure 83: Oceania Market Attractiveness Analysis, By Material
Figure 84: Oceania Market Attractiveness Analysis, Application
Figure 85: Oceania Market Attractiveness Analysis, By End User
Figure 86: MEA Market Value Share, by Country (2022)
Figure 87: MEA Market Value Share, by Product (2022)
Figure 88: MEA Market Value Share, by Material (2022)
Figure 89: MEA Market Value Share, by Application (2022)
Figure 90: MEA Market Value Share, by End User (2022)
Figure 91: MEA Market Attractiveness Analysis, By Country
Figure 92: MEA Market Attractiveness Analysis, By Product Type
Figure 93: MEA Market Attractiveness Analysis, By Material
Figure 94: MEA Market Attractiveness Analysis, Application
Figure 95: MEA Market Attractiveness Analysis, By End User
Figure 96: India Market Value Analysis (US$ Mn), 2014-2021
Figure 97: India Market Value Forecast (US$ Mn), 2022-2029
Figure 98: China Market Value Analysis (US$ Mn), 2014-2021
Figure 99: China Market Value Forecast (US$ Mn), 2022-2029
Figure 100: Brazil Market Value Analysis (US$ Mn), 2014-2021
Figure 101: Brazil Market Value Forecast (US$ Mn), 2022-2029
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports